Our mission is to provide hypertension patients with a short, effective single intervention solution for high blood pressure.
Shawn Moaddeb is an entrepreneur with over 25 years’ experience in the medical device industry. Former VP of RF Technology at Vessix Vascular, Shawn is a named inventor on over 100 issued and pending patents in the areas of RF catheter-based renal denervation, percutaneous mitral valve catheter-based therapy, electrophysiology and cardiac ablation systems, medical laser systems, GI, and implantable pacemaker and defibrillator devices.Read More
David Prutchi has been involved with ReDy since its foundation in 2012, and has held executive positions in a number of companies in the Hobart Group since 1997. He has over 25 years’ experience in biomedical R&D and medical electronic instrumentation design and management. He is the lead author of Design and Development of Medical Electronic Instrumentation – A Practical Perspective of the Design, Construction and Test of Medical Devices (2005), and co-author of Exploring Quantum Physics Through Hands-On Projects (2012).Read More
Simos Kedikoglou is a board member at ReDy and has been involved in various executive managerial roles in the Hobart Group since 2012. Prior to joining the Hobart Group, he served as Vice President of Business Development for Boston Scientific, with responsibility for acquisitions, licensing and distribution deals in the US, Europe and Asia. He was formerly an Associate Partner with McKinsey & Company in the US.Read More
Prof. Dr. Karl-Heinz Kuck is the head of the Department of Cardiology at the Asklepios Klinik in Hamburg. Throughout his career he has earned several prizes for his work, including the Science Prize of the Gertrud Spitz Foundation and a silver badge of honor from the German Society for Cardiology - Heart and Circulatory Research.Read More